Back
Black Diamond Therapeutics Vs. Vanda Pharmaceuticals Industry Stock Comparison
Sell
27
BDTX
Black Diamond Therapeutics
Last Price:
2.87
Seasonality Move:
21.63%
Sell
45
VNDA
Vanda Pharmaceuticals
Last Price:
5.10
Seasonality Move:
4.48%
Sell
27
Black Diamond Therapeutics (BDTX)
is a Sell
Is Black Diamond Therapeutics a Buy, Sell or Hold?
- The current Black Diamond Therapeutics [BDTX] share price is $2.85. The Score for BDTX is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
- BDTX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
45
Vanda Pharmaceuticals (VNDA)
is a Sell
Is Vanda Pharmaceuticals a Buy, Sell or Hold?
- The current Vanda Pharmaceuticals [VNDA] share price is $5.10. The Score for VNDA is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
- VNDA is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
BDTX Stock Price Chart
What is Black Diamond Therapeutics's stock price today?
-
The Black Diamond Therapeutics share price today is $2.85
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BDTX is experiencing selling pressure, which indicates risk of future bearish movement.
VNDA Stock Price Chart
What is Vanda Pharmaceuticals's stock price today?
-
The Vanda Pharmaceuticals share price today is $5.10
The current trend is moderately bullish and VNDA is experiencing selling pressure, which indicates risk of future bearish movement.
BDTX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.2 | Sell |
| Relative Strength Index (14 RSI): | 35.95 | Sell |
| Chaikin Money Flow: | -398563 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (2.94 - 3.36) | Sell |
| Bollinger Bands (100): | (3.56 - 5.88) | Sell |
VNDA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.14 | Buy |
| Relative Strength Index (14 RSI): | 55.48 | Buy |
| Chaikin Money Flow: | -713389 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (4.56 - 5.12) | Buy |
| Bollinger Bands (100): | (4.68 - 5.7) | Sell |
BDTX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 3.2 | Sell |
| 20-day SMA: | 3.09 | Sell |
| 50-day SMA: | 3.94 | Sell |
| 200-day SMA: | 4.9 | Sell |
| 8-day EMA: | 3.11 | Sell |
| 20-day EMA: | 3.22 | Sell |
| 50-day EMA: | 3.79 | Sell |
| 200-day EMA: | 4.4 | Sell |
VNDA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 5.15 | Sell |
| 20-day SMA: | 4.88 | Buy |
| 50-day SMA: | 4.81 | Buy |
| 200-day SMA: | 4.94 | Buy |
| 8-day EMA: | 5.16 | Sell |
| 20-day EMA: | 4.97 | Buy |
| 50-day EMA: | 4.93 | Buy |
| 200-day EMA: | 5.05 | Buy |
Black Diamond Therapeutics Earnings Growth & BDTX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.66 per share, and an increase next year of $0.02 per share.
Vanda Pharmaceuticals Earnings Growth & VNDA Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Black Diamond Therapeutics Technical Analysis
| Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Vanda Pharmaceuticals Technical Analysis
| Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||